Second Genome

  • Home
  • Our R&D
  • Our Services
  • Our Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Contact Us
  • Webinar: MyD88 signaling in intestinal epithelial cells shapes the composition of the gut microbiota

      Watch a 30 minute webinar with Dr. Charlotte Kaetzel from the University of Kentucky School of Medicine on “MyD88 signaling in intestinal epithelial cells shapes the composition of the gut microbiota.” Dr. Kaetzel and colleagues have identified major microbiome composition changes in the intestine of mice with a deletion in the critical signaling molecule involved [...]

    Intestine showing epithelia, microvilli and commensal bacteria.
  • Developing Therapies that Reshape the Microbiome

    Developing Therapies That Reshape The Microbiome
  • A Leading Partner for Microbiome Research & Development

    Second Genome Report

About Second Genome

Second Genome is developing microbiome-modulating precision therapies that address significant unmet need in disease and wellness. We utilize a proprietary discovery platform to unravel the complexity of the human microbiome and to drive advances in nutritional and pharmaceutical therapies. We also work with our global collaborators to identify novel biomarkers for classifying patient populations and to assess the impact of novel microbiome-modulating products.

Copyright © 2012 · All Rights Reserved · Second Genome

Second Genome, Inc. · Log in · Website Works by SafeHouse Web